A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
To assess the efficacy and safety of PF-3512676 administered in combination with docetaxel for the treatment of patients with advanced breast cancer.
Epistemonikos ID: 8a2e35122f0fb02dac0e195b8b0dacc2884c713d
First added on: May 04, 2024